USP Monograph Development Process and Compendial Updates

More documents

Recommendations

Info

PF Redesign• September 2008: ASM presentation and discussion• January 2009:– Implement new Guideline on Accelerated Text Vehicles(approving and posting all IRAs, RBs, and Errata monthly)– Revise USP-NF section of web site to include new official textsection– Begin dual presentation of IRAs and Errata in PF and on website for transition year• January 2010:– Online PF only– Remove official text from PF and post on web site only– Revise Guideline to reflect official text on web site only
USP31-NF26 General Notices TextResidual Solvents—The requirements are stated in ResidualSolvents together with information in Impurities in OfficialArticles . Thus all drug substances, excipients, andproducts are subject to relevant control of residual solvents, evenwhen no test is specified in the individual monograph. Therequirements have been aligned with the ICH guideline on this topic. Ifsolvents are used during production, they are of suitable quality. Inaddition, the toxicity and residual level of each solvent are taken intoconsideration, and the solvents are limited according to the principlesdefined and the requirements specified in Residual Solvents ,using the general methods presented therein or other suitablemethods. (Official July 1, 2008)
Page 1 and 2: Quality Standards for Medicines, Su
Page 4 and 5: United States PharmacopeialConventi
Page 6 and 7: Legal Recognition1848 Drug Import A
Page 9 and 10: 2005-2010 Council of ExpertsFood Ad
Page 11 and 12: 2005-2010 Expert Committee Demograp
Page 13 and 14: Why a USP-NF Monograph?• Recogniz
Page 15 and 16: Submission Information on Web Site
Page 17: USP Standards Setting ProcessMonogr
Page 20 and 21: Role of USP Expert Committees• Ev
Page 22 and 23: Flexible Monographs: Examples• Et
Page 24 and 25: Flexible Monograph ExampleTheophyll
Page 26 and 27: USP PublicationsFood Chemicals Code
Page 28 and 29: USP Reference Standards
Page 30 and 31: USP RS Development Process1. Create
Page 32 and 33: Compendial Updates
Page 34 and 35: Monograph Redesign• Well defined
Page 36 and 37: Monograph Redesign
Page 38 and 39: General Notices Redesign• Ease of
Page 40 and 41: General Notices Revision• Timelin
Page 42 and 43: Major Issues for Phase II• Issues
Page 44 and 45: Pending Monographs• Sponsors- Who
Page 46 and 47: PF Redesign• Current situation- D
Page 48 and 49: PF Redesign• Remove official text
Page 50 and 51: PF Redesign• Redesign USP-NF Web
Page 54 and 55: Residual Solvents• Organic Volat
Page 56 and 57: Residual Solvents• Classes of res
Page 58 and 59: Educational Activities• Residual
Page 60 and 61: Heavy Metals• USP is actively see
Page 62 and 63: Compendial Toolshttp://www.usp.org/
Page 64 and 65: Column Equivalency
Page 66: Quality Standards for Medicines, Su

USP Monograph Development Process and Compendial Updates

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?